Biomedical Engineering Reference
In-Depth Information
References
1. Hogan MJ, Alvaredo JA, Weddell JE. Histology of the Human Eye. Philadelphia:
W. B. SAUNDERS COMPANY, 1971.
2. Maurice DM. Physiology of the Eye. Boston: Little, Brown and Co., 1969; 6,14,5.
3. Straatsma BR, Foos RY, Spencer LM. The retina-topography and clinical corre-
lations. Symposium on the Retina and Retinal Surgery. Trans New Orleans Acad
Ophthal 1969:1.
4. Kolb H, Fernandez E, Nelson R, Jones BW. http://webvision.med.utah.edu.
Webvision, 2005.
5. Drasdo N, Fowler CW. Non-linear projection of the retinal image in a wide-angle
schematic eye. Br J Ophthalmol 1974; 58:709-14.
6. Yamada E. Some structural features of the fovea centralis in the human retina. Arch
Ophthalmol 1969; 82:151-9.
7. Alamouti B, Funk J. Retinal thickness decreases with age: an OCT study. Br J
Ophthalmol 2003; 87(7):899-901.
8. Majji AB, Humayun MS, Weiland JD, et al. Long-term histological and electrophys-
iological results of an inactive epiretinal electrode array implantation in dogs. Invest
Ophthalmol Vis Sci 1999; 40(9):2073-81.
9. Guven D, Weiland JD, Fujii G, et al. Long-term stimulation by active epiretinal
implants in normal and RCD1 dogs. J Neural Eng 2005; 2(1):S65-73.
10. Palmberg P. Diabetic retinopathy. Diabetes 1977; 26:703-9.
11. Klein R, Klein BEK, Linton KLP. Prevalence of age related maculopathy, The
Beaver Dam Eye Study. Ophthalmology 1992; 99:933-43.
12. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in
Australia. Ophthalmology 1995; 102:1450-60.
13. Vingerling JR, Dielemans I, Hoffman A, et al. The prevalence of age related
maculopathy in the Rotterdam study. Ophthalmology 1995; 102:205-10.
14. VanNewkirk MR, Nanjan MB, Wang JJ, et al. The prevalence of of age-related
maculopathy: the visual impairment project. Ophthalmology 2000; 107:1593-600.
15. Ferris FLI, Fine SL, Hyman LA. Age-related macular degeneration and blindness
due to neovascular maculopathy. Arch Ophthalmol 1984; 102:1640-2.
16. AREDS report No 8. A randomized, placebo-controlled clinical trial of high dose
supplementation with vitamins C and E, beta carotene, and zinc for age-related
macular degeneration and vision loss. Arch Ophthalmol 2001; 119:1417-36.
17. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovas-
cular maculopathy: five-year results from randomised clinical trials. Arch Ophthalmol
1991; 109:1109-14.
18. Fujii GY, De Juan E, Pieramici DJ, et al. Inferior limited macular translocation for
subfoveal choroidal neovascularisation: 1-year visual outcome and recurrence report.
Am J Ophthalmol 2002; 134(134):69-74.
19. Aisenbrey S, Lafaut B, Szurman P, et al. Macular translocation with 3608 retinotomy
for exudative age related macular degeneration. Arch Ophthalmol 2002; 120(451-9).
20. Schmidt-Erfurth U, Hasan T. Mechanisms of action of photodynamic therapy with
verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol
2000; 45:195-214.
21. Algvere PV, Libert C, Lindgarde G, Seregard S. Transpupillary thermotherapy of
predominantly occult choroidal neovascularisation in age related macular degener-
ation with 12 months follow-up. Acta Ophthalmol Scand 2003; 81:110-17.
Search WWH ::
Custom Search